Logo image of UK

UCOMMUNE INTERNATIONAL LTD-A (UK) Stock Fundamental Analysis

NASDAQ:UK - Nasdaq - KYG9449A1343 - Common Stock - Currency: USD

1.1099  0 (0%)

Fundamental Rating

1

UK gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 65 industry peers in the Real Estate Management & Development industry. UK has a bad profitability rating. Also its financial health evaluation is rather negative. UK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

UK had negative earnings in the past year.
In the past year UK has reported a negative cash flow from operations.
In the past 5 years UK always reported negative net income.
UK had negative operating cash flow in 4 of the past 5 years.
UK Yearly Net Income VS EBIT VS OCF VS FCFUK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -500M -1B -1.5B

1.2 Ratios

UK has a Return On Assets (-0.98%) which is comparable to the rest of the industry.
With a Return On Equity value of -14.22%, UK perfoms like the industry average, outperforming 44.62% of the companies in the same industry.
Industry RankSector Rank
ROA -0.98%
ROE -14.22%
ROIC N/A
ROA(3y)-45.17%
ROA(5y)-29.7%
ROE(3y)-389.99%
ROE(5y)-239%
ROIC(3y)N/A
ROIC(5y)N/A
UK Yearly ROA, ROE, ROICUK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -100 -200 -300 -400 -500

1.3 Margins

UK has a worse Gross Margin (1.10%) than 76.92% of its industry peers.
The Profit Margin and Operating Margin are not available for UK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
UK Yearly Profit, Operating, Gross MarginsUK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

More info and screens

1

2. Health

2.1 Basic Checks

UK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UK has been reduced compared to 1 year ago.
Compared to 5 years ago, UK has more shares outstanding
UK has a better debt/assets ratio than last year.
UK Yearly Shares OutstandingUK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K
UK Yearly Total Debt VS Total AssetsUK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

UK has an Altman-Z score of -13.05. This is a bad value and indicates that UK is not financially healthy and even has some risk of bankruptcy.
UK's Altman-Z score of -13.05 is on the low side compared to the rest of the industry. UK is outperformed by 86.15% of its industry peers.
A Debt/Equity ratio of 1.52 is on the high side and indicates that UK has dependencies on debt financing.
The Debt to Equity ratio of UK (1.52) is worse than 72.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.52
Debt/FCF N/A
Altman-Z -13.05
ROIC/WACCN/A
WACC7.13%
UK Yearly LT Debt VS Equity VS FCFUK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

UK has a Current Ratio of 0.65. This is a bad value and indicates that UK is not financially healthy enough and could expect problems in meeting its short term obligations.
UK has a worse Current ratio (0.65) than 78.46% of its industry peers.
UK has a Quick Ratio of 0.65. This is a bad value and indicates that UK is not financially healthy enough and could expect problems in meeting its short term obligations.
UK has a Quick ratio of 0.65. This is in the lower half of the industry: UK underperforms 73.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.65
UK Yearly Current Assets VS Current LiabilitesUK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

0

3. Growth

3.1 Past

UK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.87%, which is quite impressive.
UK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.41%.
UK shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -19.37% yearly.
EPS 1Y (TTM)98.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.13%
Revenue 1Y (TTM)-30.41%
Revenue growth 3Y-19.37%
Revenue growth 5YN/A
Sales Q2Q%-55.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UK Yearly Revenue VS EstimatesUK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

UK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UK Price Earnings VS Forward Price EarningsUK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UK Per share dataUK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UCOMMUNE INTERNATIONAL LTD-A

NASDAQ:UK (4/25/2025, 8:00:01 PM)

1.1099

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)04-13 2023-04-13
Earnings (Next)N/A N/A
Inst Owners2.18%
Inst Owner Change0%
Ins Owners2.55%
Ins Owner ChangeN/A
Market Cap1.58M
Analysts0
Price TargetN/A
Short Float %2.96%
Short Ratio1.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B 0.34
P/tB 0.36
EV/EBITDA N/A
EPS(TTM)-1.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.52
FCFYN/A
OCF(TTM)-1.8
OCFYN/A
SpS44.43
BVpS3.3
TBVpS3.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.98%
ROE -14.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.1%
FCFM N/A
ROA(3y)-45.17%
ROA(5y)-29.7%
ROE(3y)-389.99%
ROE(5y)-239%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 1.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.27%
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.65
Quick Ratio 0.65
Altman-Z -13.05
F-Score5
WACC7.13%
ROIC/WACCN/A
Cap/Depr(3y)16.52%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.35%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.41%
Revenue growth 3Y-19.37%
Revenue growth 5YN/A
Sales Q2Q%-55.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y101.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y109.66%
OCF growth 3YN/A
OCF growth 5YN/A